These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Depot antipsychotics. Patient characteristics and prescribing pattern. Al-Sughayir MA. Saudi Med J; 2000 Dec; 21(12):1178-81. PubMed ID: 11360095 [Abstract] [Full Text] [Related]
8. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)]. Polácek J. Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182 [No Abstract] [Full Text] [Related]
9. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. Mamo DC, Sweet RA, Chengappa KN, Reddy RR, Jeste DV. Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650 [Abstract] [Full Text] [Related]
13. Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany. Haring C, Tegeler J, Lehmann E, Ptock WD. Acta Psychiatr Belg; 1981 Feb; 81(2):189-202. PubMed ID: 6117189 [Abstract] [Full Text] [Related]
17. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)]. Haumonté MT, Hoerdt HP. Ann Med Psychol (Paris); 1972 Feb 17; 1(2):277-83. PubMed ID: 5051257 [No Abstract] [Full Text] [Related]
18. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice]. Richou H. Ann Med Psychol (Paris); 1975 Jul 17; 2(2):399-402. PubMed ID: 9894 [No Abstract] [Full Text] [Related]